The treatment of drug-resistant forms of tuberculosis has been transformed over the last decade with treatment becoming more effective, safer, and treatment duration in many cases dropping to under a year. Even so, treatment can still come with serious side effects and for some, it can still last over a year and a half. In a finding that may help further reduce side effects, new research has found that the dosage of a key drug can be lowered without compromising how well it works. Tiyese Jeranji and Marcus Low report.
Children shoulder approximately 12% of the global TB burden, and this proportion is likely higher in high TB burden countries. In South Africa, up to 30 000 children develop TB each year. Tiyese Jeranji spoke to TB expert, Dr Megan Palmer from Brooklyn Chest Hospital about treatment challenges and how to improve TB detection and treatment outcomes in children.
A World Health Organization report published last week showed more people are falling ill with tuberculosis in South Africa than previously thought – but also that the country’s treatment success rate for dangerous drug-resistant forms of the disease have improved. Amy Green asks what’s behind these numbers.
With chronic health worker shortages and limited resources such as ventilators in rural public health facilities, how did Zithulele Hospital in OR Tambo District manage its COVID-19 cases? Tiyese Jeranji spoke to two doctors working at Zithulele about an innovative oxygen solution, infection control, and much more.
Even though it has been ready for months, findings of a critically important tuberculosis survey have not been made public. Every day that passes, the more outdated the findings become, and accordingly the less useful.
Tuberculosis (TB) testing rates are down by almost half and dramatically fewer TB patients are starting treatment. Kathryn Cleary takes an in-depth look at the impact of COVID-19 and the lockdown on TB services in South Africa.